Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species

Parasitology Research

Volumn 107, Issue 1, 2010, Pages 205-212

  Liarte, Daniel B ^a   Murta, Silvane M F ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIMONY TARTRATE; MILTEFOSINE; PAROMOMYCIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; INFECTION; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA INFANTUM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMALS; ANTIMONY POTASSIUM TARTRATE; ANTIPROTOZOAL AGENTS; CULTURE MEDIA; DRUG RESISTANCE; INHIBITORY CONCENTRATION 50; LEISHMANIA; LEISHMANIASIS; LIVER; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PAROMOMYCIN; PHENOTYPE; PHOSPHORYLCHOLINE; SELECTION, GENETIC; SERIAL PASSAGE; SPLEEN; VIRULENCE;

LEISHMANIA AMAZONENSIS; LEISHMANIA BRAZILIENSIS; MUS;

EID: 77953651743     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-010-1852-8     Document Type: Article

References (46)

1. HI Al-Mohammed ML Chance PA Bates 2005 Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana Antimicrob Agents Chemother 49 8 3274 3280 10.1128/AAC.49.8.3274-3280. 2005 1:CAS:528:DC%2BD2MXntFChtbw%3D 16048936 (Pubitemid 41060571)
2. C Anacleto MC Abdo AV Ferreira SM Murta AJ Romanha AP Fernandes ES Moreira 2003 Structural and functional analysis of an amplification containing a PGPA gene in a glucantime-resistant Leishmania (Viannia) guyanensis cell line Parasitol Res 90 2 110 118 12756544
3. FE Arana JM Pérez-Victoria Y Repetto A Morello S Castanys F Gamarro 1998 Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica Biochem Pharmacol 56 1201 1208 10.1016/S0006-2952(98)00129-4 1:CAS:528:DyaK1cXnt1Oht7Y%3D 9802332 (Pubitemid 28511244)
4. M Basselin M Robert-Gero 1998 Alterations in membrane fluidity, lipid metabolism, mitochondrial activity, and lipophosphoglycan expression in pentamidine-resistant Leishmania Parasitol Res 84 1 78 83 10.1007/s004360050361 1:STN:280:DyaK1c7lt1WgsA%3D%3D 9491432 (Pubitemid 28097631)
5. JD Berman G Ksionski WL Chapman VB Waits WL Hanson 1992 Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis Antimicrob Agents Chemother 36 1978 1980 1:CAS:528: DyaK38Xmt1Gku7s%3D 1416890
6. C Bories S Cojean F Huteau PM Loiseau 2008 Selection and phenotype characterisation of sitamaquine-resistant promastigotes of Leishmania donovani Biomed Pharmacother 62 164 167 10.1016/j.biopha.2007.12.006 1:CAS:528: DC%2BD1cXjs1Wgs70%3D 18249083 (Pubitemid 351381937)
7. C Brochu J Wang G Roy N Messier XY Wang NG Saravia M Ouellette 2003 Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites Antimicrob Agents Chemother 47 3073 3079 10.1128/AAC.47.10.3073-3079.2003 1:CAS:528:DC%2BD3sXnvVWmsLg%3D 14506011 (Pubitemid 37229559)
8. Centers for Disease Control and Prevention (2009) Available from: www.dpd.cdc.gov/dpdx/HTML/Leishmaniasis.htm. Reviewed November 14
9. SL Croft 2001 Monitoring drug resistance in leishmaniasis Trop Med Int Health 6 11 899 905 10.1046/j.1365-3156.2001.00754.x 1:CAS:528: DC%2BD3MXotlykur4%3D 11703844 (Pubitemid 33010876)
10. SL Croft S Sundar AH Fairlamb 2006 Drug resistance in leishmaniasis Clin Microbiol Rev 19 111 126 10.1128/CMR.19.1.111-126.2006 1:CAS:528: DC%2BD28XhsFGjtbk%3D 16418526 (Pubitemid 43157649)
11. ML Cunningham RG Titus SJ Turco SM Beverley 2001 Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin Science 292 285 287 10.1126/science.1057740 1:CAS:528:DC%2BD3MXivVygsrg%3D 11303103 (Pubitemid 32295386)
12. RN Davidson SL Croft A Scott M Maini AH Moody AD Bryceson 1991 Liposomal amphotericin B in drug-resistant visceral leishmaniasis Lancet 337 1061 1062 10.1016/0140-6736(91)91708-3 1:STN:280:DyaK3M3htFGjtQ%3D%3D 1673494
13. JC de Roode R Culleton AS Bell AF Read 2004 Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections Malar J 14 33 10.1186/1475-2875-3-33 (Pubitemid 39363936)
14. S Decuypere S Rijal V Yardley S De Doncker T Laurent B Khanal F Chappuis JC Dujardin 2005 Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal Antimicrob Agents Chemother 49 11 4616 4621 10.1128/AAC.49.11.4616-4621.2005 1:CAS:528: DC%2BD2MXht1Siu7zK 16251303 (Pubitemid 41552591)
15. S Dey B Papadopoulou A Haimeur G Roy K Grondin D Dou BP Rosen M Ouellette 1994 High level arsenite resistance in Leishmania tarentolae is mediated by an active extrusion system Mol Biochem Parasitol 67 1 49 57 10.1016/0166-6851(94) 90095-7 1:CAS:528:DyaK2cXmslCmurw%3D 7838183 (Pubitemid 24287310)
16. K El Fadili N Messier P Leprohon G Roy C Guimond N Trudel NG Saravia B Papadopoulou D Légaré M Ouellette 2005 Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes Antimicrob Agents Chemother 49 1988 1993 10.1128/AAC.49.5.1988-1993.2005 1:CAS:528:DC%2BD2MXktFSntbo%3D 15855523 (Pubitemid 40631616)
17. N García K Figarella A Mendoza-León A Ponte-Sucre 2000 Changes in the infectivity, pyruvate kinase activity, acid phosphatase activity and P-glycoprotein expression in glibenclamide-resistant Leishmania mexicana Parasitol Res 86 11 899 904 10.1007/s004360000257 11097297
18. KC Gazola AV Ferreira C Anacleto MS Michalick AF Andrade ES Moreira 2001 Cell surface carbohydrates and in vivo infectivity of glucantime-sensitive and resistant Leishmania (Viannia) guyanensis cell lines Parasitol Res 87 11 935 940 1:STN:280:DC%2BD3MnotFGnsQ%3D%3D 11728019
19. AM Geretti 2005 The clinical significance of viral fitness J HIV Ther 10 1 6 10 1:CAS:528:DC%2BD2MXksFCmsrs%3D 15951728
20. B Gourbal N Sonuc H Bhattacharjee D Legare S Sundar M Ouellette BP Rosen R Mukhopadhyay 2004 Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin J Biol Chem 279 30 31010 31017 10.1074/jbc.M403959200 1:CAS:528:DC%2BD2cXlslOktbw%3D 15138256 (Pubitemid 39037760)
21. A Haimeur C Brochu P Genest B Papadopoulou M Ouellette 2000 Amplification of the ABC transporter gene PGPA and increased trypanothione levels in potassium antimonyl tartrate (SbIII) resistant Leishmania tarentolae Mol Biochem Parasitol 108 131 135 10.1016/S0166-6851(00)00187-0 1:CAS:528: DC%2BD3cXjtVCis7o%3D 10802326 (Pubitemid 30236323)
22. R Hayward KJ Saliba K Kirk 2005 pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum Mol Microbiol 55 1285 1295 10.1111/j.1365-2958.2004.04470.x 1:CAS:528: DC%2BD2MXit1emurg%3D 15686571 (Pubitemid 40299194)
23. BL Herwaldt 1999 Leishmaniasis Lancet 354 1191 1199 10.1016/S0140- 6736(98)10178-2 1:STN:280:DyaK1MvktFyrtg%3D%3D 10513726 (Pubitemid 29460458)
24. A Jhingran B Chawla S Saxena MP Barrett R Madhubala 2009 Paromomycin: uptake and resistance in Leishmania donovani Mol Biochem Parasitol 164 111 117 10.1016/j.molbiopara.2008.12.007 1:CAS:528:DC%2BD1MXitVGitLo%3D 19146886
25. RE Lenski 1998 Bacterial evolution and the cost of antibiotic resistance Int Microbiol 1 4 265 270 1:STN:280:DC%2BD3cvhtFOqtA%3D%3D 10943373
26. M Lipoldova P Demant 2006 Genetic susceptibility to infectious disease: lessons from mouse models of leishmaniasis Nat Rev Genet 7 294 305 10.1038/nrg1832 1:CAS:528:DC%2BD28XisFWgtLY%3D 16543933
27. R Lira S Mendez L Carrera C Jaffe F Neva D Sacks 1998 Leishmania tropica: the identification and purification of metacyclic promastigotes and use in establishing mouse and hamster models of cutaneous and visceral disease Exp Parasitol 89 331 342 10.1006/expr.1998.4283 1:STN:280:DyaK1czjvFegsQ%3D%3D 9676711 (Pubitemid 28375781)
28. C Ma J Tran C Li L Ganesan D Wood N Morrissette 2008 Secondary mutations correct fitness defects in Toxoplasma gondii with dinitroaniline resistance mutations Genetics 180 2 845 856 10.1534/genetics.108.092494 1:CAS:528:DC%2BD1cXhtlWnurrO 18780736
29. N Marquis B Gourbal BP Rosen R Mukhopadhyay M Ouellette 2005 Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistant Leishmania Mol Microbiol 57 6 1690 1699 10.1111/j.1365-2958.2005.04782.x 1:CAS:528: DC%2BD2MXhtVKqsrrP 16135234 (Pubitemid 41337396)
30. PD Marsden 1986 Mucosal leishmaniasis ('espundia' Escomel, 1911) Trans R Soc Trop Med Hyg 80 859 876 10.1016/0035-9203(86)90243-9 1:STN:280: DyaL2s3msVKqsA%3D%3D 3037735
31. N Mbongo PM Loiseau MA Billion M Robert-Gero 1998 Mechanism of amphotericin B resistance in Leishmania donovani promastigotes Antimicrob Agents Chemother 42 352 357 1:CAS:528:DyaK1cXnsFKjsA%3D%3D 9527785 (Pubitemid 28114444)
32. ES Moreira C Anacleto ML Petrillo-Peixoto 1998 Effect of glucantime on field and patient isolates of New World Leishmania: use of growth parameters of promastigotes to assess antimony susceptibility Parasitol Res 84 720 726 10.1007/s004360050476 1:STN:280:DyaK1cvjvVaqsg%3D%3D 9766900 (Pubitemid 28408672)
33. S Natera C Machuca M Padrón-Nieves A Romero E Díaz A Ponte-Sucre 2007 Leishmania spp.: proficiency of drug-resistant parasites Int J Antimicrob Agents 29 6 637 642 10.1016/j.ijantimicag.2007.01.004 1:CAS:528:DC%2BD2sXlt1agurk%3D 17353113 (Pubitemid 46710356)
34. M Ouellette J Drummelsmith B Papadopoulou 2004 Leishmaniasis: drugs in the clinic, resistance and new developments Drug Resist Updat 7 4-5 257 266 10.1016/j.drup.2004.07.002 1:CAS:528:DC%2BD2cXpsVOlu7c%3D 15533763 (Pubitemid 39469098)
35. GA Romero MV Guerra MG Paes VO Macêdo 2001 Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate Am J Trop Med Hyg 65 456 465 1:CAS:528:DC%2BD3MXptVehtbc%3D 11716098
36. K Seifert S Matu F Javier Pérez-Victoria S Castanys F Gamarro SL Croft 2003 Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine) Int J Antimicrob Agents 22 380 387 10.1016/S0924-8579(03)00125-0 1:CAS:528:DC%2BD3sXns12msLg%3D 14522101 (Pubitemid 37163727)
37. D Sereno M Cavaleyra K Zemzoumi S Maquaire A Ouaissi JL Lemesre 1998 Axenically grown amastigotes of Leishmania infantum used as an in vitro model to investigate the pentavalent antimony mode of action Antimicrob Agents Chemother 42 3097 3102 1:STN:280:DyaK1M%2FlsVynug%3D%3D 9835497
38. D Sereno P Holzmuller JL Lemesre 2000 Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum Acta Trop 74 25 31 10.1016/S0001-706X(99)00048-0 1:CAS:528:DyaK1MXns1ahuro%3D 10643904
39. P Shaked-Mishan N Ulrich M Ephros D Zilberstein 2001 Novel intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani J Biol Chem 276 3971 3976 10.1074/jbc.M005423200 1:CAS:528: DC%2BD3MXht1Ggur8%3D 11110784
40. JJ Shaw 2006 Further thoughts on the use of the name Leishmania (Leishmania) infantum chagasi for the aetiological agent of American visceral leishmaniasis Mem Inst Oswaldo Cruz 101 577 579 10.1590/S0074-02762006000500017 17072466
41. O Shimony CL Jaffe 2008 Rapid fluorescent assay for screening drugs on Leishmania amastigotes J Microbiol Methods 75 2 196 200 10.1016/j.mimet.2008.05. 026 1:CAS:528:DC%2BD1cXhtV2jsbfO 18573286
42. S Sundar 2001 Drug resistance in Indian visceral leishmaniasis Trop Med Int Health 6 849 854 10.1046/j.1365-3156.2001.00778.x 1:STN:280: DC%2BD3MnltFOqsQ%3D%3D 11703838 (Pubitemid 33010870)
43. S Sundar DK More MK Singh VP Singh S Sharma A Makharia PC Kumar HW Murray 2000 Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic Clin Infect Dis 31 1104 1107 10.1086/318121 1:STN:280:DC%2BD3M7htVagug%3D%3D 11049798 (Pubitemid 32299375)
44. CP Thakur S Thakur S Narayan A Sinha 2008 Comparison of treatment regimens of kala-azar based on culture & sensitivity of amastigotes to sodium antimony gluconate Indian J Med Res 127 582 588 1:STN:280: DC%2BD1crnslGisQ%3D%3D 18765878
45. D Walliker P Hunt H Babiker 2005 Fitness of drug-resistant malaria parasites Acta Trop 94 251 259 1:CAS:528:DC%2BD2MXks1agtLc%3D 15845348 Review
46. S Wyllie ML Cunningham AH Fairlamb 2004 Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani J Biol Chem 279 39925 39932 10.1074/jbc.M405635200 1:CAS:528:DC%2BD2cXnsVKku7k%3D 15252045 (Pubitemid 39258265)